OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
Luciana Mosca, Andrea Ilari, Francesco Fazi, et al.
Drug Resistance Updates (2021) Vol. 54, pp. 100742-100742
Closed Access | Times Cited: 218
Luciana Mosca, Andrea Ilari, Francesco Fazi, et al.
Drug Resistance Updates (2021) Vol. 54, pp. 100742-100742
Closed Access | Times Cited: 218
Showing 26-50 of 218 citing articles:
Role of E2F transcription factor in oral cancer: Recent insight and advancements
Amal Kassab, Ishita Gupta, Ala‐Eddin Al Moustafa
Seminars in Cancer Biology (2023) Vol. 92, pp. 28-41
Open Access | Times Cited: 31
Amal Kassab, Ishita Gupta, Ala‐Eddin Al Moustafa
Seminars in Cancer Biology (2023) Vol. 92, pp. 28-41
Open Access | Times Cited: 31
Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
Onyinyechi Obidiro, Gantumur Battogtokh, Emmanuel O. Akala
(2023)
Open Access | Times Cited: 30
Onyinyechi Obidiro, Gantumur Battogtokh, Emmanuel O. Akala
(2023)
Open Access | Times Cited: 30
Microtubule‐targeting agents for cancer treatment: Seven binding sites and three strategies
Xingyu Wang, Benoı̂t Gigant, Xi Zheng, et al.
MedComm – Oncology (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 27
Xingyu Wang, Benoı̂t Gigant, Xi Zheng, et al.
MedComm – Oncology (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 27
Mitotic Functions and Characters of KIF11 in Cancers
Wanting Gao, Junjie Lu, Zitao Yang, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 386-386
Open Access | Times Cited: 10
Wanting Gao, Junjie Lu, Zitao Yang, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 386-386
Open Access | Times Cited: 10
Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options
Hongli Gao, Zhuo Xi, Jingwei Dai, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Hongli Gao, Zhuo Xi, Jingwei Dai, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Protein arginine methyltransferases (PRMTs): Orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance
Yihang Gao, Chongchong Feng, Jingru Ma, et al.
Biochemical Pharmacology (2024) Vol. 221, pp. 116048-116048
Closed Access | Times Cited: 7
Yihang Gao, Chongchong Feng, Jingru Ma, et al.
Biochemical Pharmacology (2024) Vol. 221, pp. 116048-116048
Closed Access | Times Cited: 7
Thermo-sensitive PLGA-PEG-PLGA hydrogel for sustained release of EGF to inhibit cervical cancer recurrence
Piao Li, Peng Xiang, Yangyang Zhou, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 236, pp. 113795-113795
Closed Access | Times Cited: 7
Piao Li, Peng Xiang, Yangyang Zhou, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 236, pp. 113795-113795
Closed Access | Times Cited: 7
RNF31 induces paclitaxel resistance by sustaining ALYREF cytoplasmic–nuclear shuttling in human triple‐negative breast cancer
Shu‐Mei Huang, Dongni Shi, Shuqin Dai, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 2
Open Access
Shu‐Mei Huang, Dongni Shi, Shuqin Dai, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 2
Open Access
In vitro biomimetic models for glioblastoma-a promising tool for drug response studies
Tijana Stanković, Teodora Ranđelović, Miodrag Dragoj, et al.
Drug Resistance Updates (2021) Vol. 55, pp. 100753-100753
Open Access | Times Cited: 42
Tijana Stanković, Teodora Ranđelović, Miodrag Dragoj, et al.
Drug Resistance Updates (2021) Vol. 55, pp. 100753-100753
Open Access | Times Cited: 42
Targeting Heat-Shock Protein 90 in Cancer: An Update on Combination Therapy
Xiude Ren, Tao Li, Wei Zhang, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2556-2556
Open Access | Times Cited: 28
Xiude Ren, Tao Li, Wei Zhang, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2556-2556
Open Access | Times Cited: 28
Network biology and artificial intelligence drive the understanding of the multidrug resistance phenotype in cancer
Beatriz Bueschbell, Ana B. Caniceiro, Pedro M. S. Suzano, et al.
Drug Resistance Updates (2022) Vol. 60, pp. 100811-100811
Open Access | Times Cited: 27
Beatriz Bueschbell, Ana B. Caniceiro, Pedro M. S. Suzano, et al.
Drug Resistance Updates (2022) Vol. 60, pp. 100811-100811
Open Access | Times Cited: 27
Perspectives and mechanisms for targeting mitotic catastrophe in cancer treatment
Zhaoshi Bai, Yiran Zhou, Yaling Peng, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188965-188965
Closed Access | Times Cited: 19
Zhaoshi Bai, Yiran Zhou, Yaling Peng, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188965-188965
Closed Access | Times Cited: 19
Ganoderma lucidum extract promotes tumor cell pyroptosis and inhibits metastasis in breast cancer
Chunlian Zhong, Yumei Li, Wulin Li, et al.
Food and Chemical Toxicology (2023) Vol. 174, pp. 113654-113654
Closed Access | Times Cited: 16
Chunlian Zhong, Yumei Li, Wulin Li, et al.
Food and Chemical Toxicology (2023) Vol. 174, pp. 113654-113654
Closed Access | Times Cited: 16
Role Of YAP Signaling in Regulation of Programmed Cell Death and Drug Resistance in Cancer
Wei Zhou, Adrian Lim, Mouad Edderkaoui, et al.
International Journal of Biological Sciences (2023) Vol. 20, Iss. 1, pp. 15-28
Open Access | Times Cited: 15
Wei Zhou, Adrian Lim, Mouad Edderkaoui, et al.
International Journal of Biological Sciences (2023) Vol. 20, Iss. 1, pp. 15-28
Open Access | Times Cited: 15
Exploiting epigenetic targets to overcome taxane resistance in prostate cancer
Buse Cevatemre, Ipek Bulut, Beyza Dedeoğlu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 6
Buse Cevatemre, Ipek Bulut, Beyza Dedeoğlu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 6
Targeting RAF dimers in RAS mutant tumors: From biology to clinic
Huanhuan Yin, Qiulin Tang, Hongwei Xia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 1895-1923
Open Access | Times Cited: 6
Huanhuan Yin, Qiulin Tang, Hongwei Xia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 1895-1923
Open Access | Times Cited: 6
Blocking the WNT/β-catenin pathway in cancer treatment:pharmacological targets and drug therapeutic potential
Xi Zhao, Yunong Ma, Jiayang Luo, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e35989-e35989
Open Access | Times Cited: 6
Xi Zhao, Yunong Ma, Jiayang Luo, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e35989-e35989
Open Access | Times Cited: 6
Combination therapy involving HSP90 inhibitors for combating cancer: an overview of clinical and preclinical progress
Yajun Liu, Chenyao Li, Hongwei Liu, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 5, pp. 442-464
Closed Access | Times Cited: 5
Yajun Liu, Chenyao Li, Hongwei Liu, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 5, pp. 442-464
Closed Access | Times Cited: 5
The Second Selectivity of Taxanes to Malignant Cells --- Nuclear Envelope Malleability
Xiang‐Xi Xu, Elizabeth R. Smith
Journal of Cancer (2025) Vol. 16, Iss. 4, pp. 1051-1053
Open Access
Xiang‐Xi Xu, Elizabeth R. Smith
Journal of Cancer (2025) Vol. 16, Iss. 4, pp. 1051-1053
Open Access
Synthesis and Screening of Novel 2,4-Bis Substituted quinazolines as Tubulin Polymerization Promotors and Antiproliferative Agents
Ashish Ranjan Dwivedi, Vijay Kumar, Vikash Prashar, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Ashish Ranjan Dwivedi, Vijay Kumar, Vikash Prashar, et al.
RSC Medicinal Chemistry (2025)
Closed Access
New Compounds with Enhanced Biological Activity Through the Strategic Introduction of Silylated Groups into Hydroxystearic Acids
Chiara Zalambani, Lorenzo Anconelli, Natalia Calonghi, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 440-440
Open Access
Chiara Zalambani, Lorenzo Anconelli, Natalia Calonghi, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 440-440
Open Access
Establishment of a chemoresistant laryngeal cancer cell model to study chemoresistance and chemosensitization responses via transcriptomic analysis and a tumor‐on‐a‐chip platform
Christian R. Moya‐Garcia, Meghana Munipalle, Alain Pacis, et al.
Bioengineering & Translational Medicine (2025)
Open Access
Christian R. Moya‐Garcia, Meghana Munipalle, Alain Pacis, et al.
Bioengineering & Translational Medicine (2025)
Open Access
Applications and Enhancement Strategies of ROS-based Non-invasive Therapies in Cancer Treatment
Qiuyan Guo, Yingnan Tang, Shengmei Wang, et al.
Redox Biology (2025), pp. 103515-103515
Open Access
Qiuyan Guo, Yingnan Tang, Shengmei Wang, et al.
Redox Biology (2025), pp. 103515-103515
Open Access
Natural products as part of triple negative breast cancer
Yozlem Kobakova, Maria Moneva-Sakelarieva, Spiro Konstantinov, et al.
Pharmacia (2025) Vol. 72, pp. 1-11
Open Access
Yozlem Kobakova, Maria Moneva-Sakelarieva, Spiro Konstantinov, et al.
Pharmacia (2025) Vol. 72, pp. 1-11
Open Access
In-silico investigation of alpha-bisabolol and derivatives as inhibitors of bcl-2 family proteins for targeting glioblastoma
Nilüfer Vural, Sibel Kaymak
International Journal of Secondary Metabolite (2025) Vol. 12, Iss. 1, pp. 1-15
Open Access
Nilüfer Vural, Sibel Kaymak
International Journal of Secondary Metabolite (2025) Vol. 12, Iss. 1, pp. 1-15
Open Access
